A detailed history of N Verses Capital, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, N Verses Capital, LLC holds 7,200 shares of NVCR stock, worth $135,216. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,200
Previous 8,100 11.11%
Holding current value
$135,216
Previous $139 Million 18.89%
% of portfolio
0.05%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$15.61 - $23.34 $14,049 - $21,006
-900 Reduced 11.11%
7,200 $113 Million
Q2 2024

Jul 31, 2024

BUY
$11.83 - $24.05 $50,869 - $103,415
4,300 Added 113.16%
8,100 $139 Million
Q1 2024

Apr 25, 2024

BUY
$12.42 - $17.29 $47,196 - $65,702
3,800 New
3,800 $59.4 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.97B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.